share_log

Aurora Improves Offerings in Australia With New Range of Premium Dried Flower Products

PR Newswire ·  Apr 30 07:15

NASDAQ | TSX: ACB

Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for Patients

EDMONTON, AB, April 30, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – the Canadian based leading global medical cannabis company, in conjunction with MedReleaf Australia, is pleased to announce the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. Now available for doctors to prescribe to patients in Australia, the new products developed by Aurora and manufactured at its EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia, a premier distributor of medical cannabis products holding the second position in the Australian market.

Vespera (CNW Group/Aurora Cannabis Inc.)
Moon Berry (CNW Group/Aurora Cannabis Inc.)
Black Jelly (CNW Group/Aurora Cannabis Inc.)
Chemango Kush (CNW Group/Aurora Cannabis Inc.)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment